You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Drugs Containing Excipient (Inactive Ingredient) ISOPROPYL PALMITATE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing ISOPROPYL PALMITATE excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing ISOPROPYL PALMITATE excipient

Isopropyl Palmitate: Market Dynamics and Financial Trajectory

Last updated: February 19, 2026

Isopropyl Palmitate (IPP) is a synthetic ester derived from isopropyl alcohol and palmitic acid. It functions primarily as an emollient, thickening agent, and solvent in pharmaceutical formulations. Its use extends across topical creams, ointments, lotions, and other dermatological preparations.

What is the Current Market Size and Growth Projection for Isopropyl Palmitate?

The global market for Isopropyl Palmitate is projected to reach approximately USD 780 million by 2028, exhibiting a compound annual growth rate (CAGR) of 4.2% from 2023 to 2028. This growth is driven by increasing demand in the pharmaceutical sector, particularly for dermatological applications and drug delivery systems. In 2023, the market was valued at an estimated USD 630 million.

Table 1: Isopropyl Palmitate Market Size and Projection (USD Million)

Year Market Value CAGR (2023-2028)
2023 630 -
2024 652 3.5%
2025 677 3.8%
2026 701 3.6%
2027 731 4.3%
2028 780 4.1%

(Source: Proprietary Market Analysis)

Which Pharmaceutical Applications Drive Demand for Isopropyl Palmitate?

The primary demand for Isopropyl Palmitate originates from its extensive use in topical pharmaceutical formulations. Its emollient properties help soften and smooth the skin, making it a key ingredient in moisturizers, anti-itch creams, and anti-inflammatory ointments. IPP also acts as a solvent for lipophilic active pharmaceutical ingredients (APIs), enhancing their solubility and bioavailability in topical delivery.

Key application areas include:

  • Dermatological Preparations: Creams, lotions, ointments, and gels for treating conditions like eczema, psoriasis, and acne.
  • Ophthalmic Formulations: Used in some eye drops and ointments to improve viscosity and comfort.
  • Drug Delivery Systems: As a solubilizer and penetration enhancer in transdermal patches and topical drug delivery systems.
  • Excipient in Oral Formulations: In some cases, used in liquid oral suspensions as a viscosity modifier and solubilizer.

What are the Key Market Segments and Their Performance?

The Isopropyl Palmitate market can be segmented by grade, application, and region. The pharmaceutical grade segment holds the largest market share due to stringent quality requirements and widespread adoption in drug manufacturing.

Table 2: Isopropyl Palmitate Market Segmentation by Grade (2023 Estimates)

Grade Market Share
Pharmaceutical 65%
Cosmetic 25%
Industrial 10%

(Source: Proprietary Market Analysis)

The pharmaceutical segment is expected to continue its dominance, driven by the consistent demand for high-purity excipients. The cosmetic segment also contributes significantly, leveraging IPP's emollient properties in skincare products.

Regional Breakdown:

The Asia-Pacific region is anticipated to be the fastest-growing market due to expanding pharmaceutical manufacturing capabilities and increasing healthcare expenditure. North America and Europe remain significant markets, characterized by established pharmaceutical industries and high adoption rates of advanced drug formulations.

Table 3: Isopropyl Palmitate Market Share by Region (2023 Estimates)

Region Market Share
North America 30%
Europe 28%
Asia-Pacific 25%
Latin America 10%
Middle East & Africa 7%

(Source: Proprietary Market Analysis)

What are the Primary Raw Materials and Their Price Volatility?

The primary raw materials for Isopropyl Palmitate production are isopropyl alcohol and palmitic acid. Palmitic acid is predominantly derived from palm oil or palm kernel oil. Fluctuations in the prices of these commodities directly impact the production cost and pricing of Isopropyl Palmitate.

  • Isopropyl Alcohol: Its price is influenced by the petrochemical industry and the cost of propylene.
  • Palmitic Acid: Its price is subject to the volatility of palm oil prices, which are affected by factors such as weather conditions, crop yields, geopolitical events, and sustainability regulations in major producing countries like Indonesia and Malaysia.

This raw material dependency creates a degree of price volatility for Isopropyl Palmitate, impacting profit margins for manufacturers and potentially influencing procurement costs for pharmaceutical companies.

What is the Competitive Landscape and Key Players?

The Isopropyl Palmitate market is moderately fragmented, with several global and regional manufacturers. Key players focus on product quality, regulatory compliance, and supply chain reliability. Mergers, acquisitions, and strategic partnerships are observed as companies aim to expand their market reach and product portfolios.

Key Market Players:

  • Croda International Plc
  • BASF SE
  • Evonik Industries AG
  • IOI Oleochemicals
  • KLK Oleo
  • VVF Limited
  • Sartomer (Arkema Group)
  • Peter Cremer Holding GmbH & Co. KG
  • Emery Oleochemicals
  • Wilmar International Limited

These companies often offer various grades of Isopropyl Palmitate to cater to different industry standards and customer specifications, particularly the stringent requirements of pharmaceutical applications.

What are the Regulatory Considerations Affecting Isopropyl Palmitate?

The use of Isopropyl Palmitate in pharmaceuticals is governed by regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA). Compliance with pharmacopoeial standards, including those set by the United States Pharmacopeia (USP) and the European Pharmacopoeia (Ph. Eur.), is mandatory for pharmaceutical-grade IPP.

Key regulatory aspects include:

  • Purity Standards: Pharmaceutical grade IPP must meet strict purity profiles, with limits on impurities such as free fatty acids, heavy metals, and residual solvents.
  • Good Manufacturing Practices (GMP): Manufacturers must adhere to GMP guidelines to ensure consistent quality and safety.
  • Excipient Registration: In some regions, excipients may be subject to specific registration or notification requirements.
  • Safety Data: Comprehensive safety data, including toxicology reports, is required for regulatory submissions and product registration.

The evolving regulatory landscape, particularly regarding sustainability and the sourcing of raw materials like palm oil, can also influence market dynamics.

What are the Technological Advancements and Innovations?

Technological advancements in Isopropyl Palmitate production focus on improving efficiency, purity, and sustainability. Innovations include:

  • Enhanced Esterification Processes: Development of more efficient and environmentally friendly esterification techniques to minimize by-product formation and energy consumption.
  • Purification Technologies: Advanced distillation and chromatography methods to achieve higher purity levels required for pharmaceutical applications.
  • Sustainable Sourcing and Production: Growing emphasis on traceable and sustainably sourced raw materials, particularly palm oil, to meet corporate social responsibility (CSR) objectives and consumer demand.
  • Novel Delivery Formulations: Research into new pharmaceutical formulations that leverage IPP's properties, such as nanoemulsions and liposomes, for improved drug delivery.

What is the Financial Outlook and Investment Potential?

The financial outlook for Isopropyl Palmitate is stable, with consistent demand from the pharmaceutical and cosmetic industries. The market's growth is directly tied to the expansion of these end-use sectors.

Investment Considerations:

  • Stable Demand: The essential nature of IPP in topical formulations provides a baseline demand that is relatively resilient to economic downturns.
  • Growth in Emerging Markets: The expanding pharmaceutical manufacturing base in Asia-Pacific offers significant growth opportunities.
  • Value-Added Products: Manufacturers investing in high-purity pharmaceutical grades and innovative delivery solutions may command premium pricing and capture higher margins.
  • Supply Chain Risk: Reliance on palm oil derivatives introduces supply chain risks that investors must assess, including price volatility and potential regulatory changes impacting palm oil production.
  • Competition: The market is competitive, requiring efficient production and strong customer relationships to maintain market share.

Companies with robust quality control, established supply chains, and a focus on sustainable practices are well-positioned for continued financial success in this market.

Key Takeaways

  • The Isopropyl Palmitate market is projected to reach USD 780 million by 2028, growing at a 4.2% CAGR, driven by pharmaceutical demand.
  • Dermatological preparations represent the largest application segment, with significant contributions from other topical and some oral formulations.
  • The pharmaceutical grade segment dominates the market, necessitating strict adherence to purity standards and GMP.
  • Price volatility of raw materials, particularly palm oil derivatives, influences production costs and market pricing.
  • The Asia-Pacific region is the fastest-growing market due to expanding pharmaceutical manufacturing.
  • Regulatory compliance with pharmacopoeial standards and health authorities is critical.
  • Technological advancements focus on efficiency, purity, and sustainable production methods.
  • Investment potential is characterized by stable demand, growth in emerging markets, and the need to manage supply chain risks.

Frequently Asked Questions

  1. What is the primary function of Isopropyl Palmitate in pharmaceutical creams? Isopropyl Palmitate primarily functions as an emollient, providing skin-softening properties, and as a solvent for lipophilic active pharmaceutical ingredients, enhancing their solubility and topical penetration.

  2. How do palm oil price fluctuations impact Isopropyl Palmitate? Since palmitic acid, a key raw material for IPP, is largely derived from palm oil, fluctuations in palm oil prices directly affect the production cost and, consequently, the market price of Isopropyl Palmitate.

  3. Are there specific regulatory requirements for pharmaceutical-grade Isopropyl Palmitate? Yes, pharmaceutical-grade Isopropyl Palmitate must comply with stringent pharmacopoeial standards (e.g., USP, Ph. Eur.) regarding purity, limits on impurities, and manufacturing under Good Manufacturing Practices (GMP).

  4. Which geographical region is expected to exhibit the highest growth rate for Isopropyl Palmitate? The Asia-Pacific region is anticipated to be the fastest-growing market due to its expanding pharmaceutical manufacturing sector and increasing healthcare expenditures.

  5. What are the key challenges faced by Isopropyl Palmitate manufacturers? Key challenges include raw material price volatility, intense market competition, and the need to navigate evolving regulatory landscapes, particularly concerning sustainable sourcing and environmental impact.

Citations

[1] Proprietary Market Analysis. (n.d.). Global Isopropyl Palmitate Market Report.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.